Mesenchymal Chondrosarcoma
📧 Sign up to get email alerts when something new happens for Mesenchymal Chondrosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma [Phase 2]
A Phase 2 clinical trial of Trabectedin for advanced rearranged mesenchymal chondrosarcoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes [Phase 2]
Phase 2 trial evaluating oral regorafenib across selected sarcoma subtypes has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma [Phase 2]
Phase 2 trial evaluating sirolimus with cyclophosphamide in metastatic or unresectable myxoid liposarcoma and chondrosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Vismodegib in Treating Patients With Advanced Chondrosarcomas [Phase 2]
Phase 2 clinical trial evaluating vismodegib for advanced chondrosarcomas has posted results in 2019 and is currently not recruiting.